Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 May 5:2019:3646975.
doi: 10.1155/2019/3646975. eCollection 2019.

Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics

Lech Chrostek  1 , Dagmara Przekop  1 , Ewa Gruszewska  1 , Monika Gudowska-Sawczuk  1 , Bogdan Cylwik  2
Affiliations
Randomized Controlled Trial

Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics

Lech Chrostek et al. Biomed Res Int. .

Abstract

The aim of this study was to evaluate the diagnostic values of noninvasive indirect markers of liver fibrosis: APRI, GAPRI, Forns, FIB-4, Age-Platelet, and Hepascore in alcoholics. Blood samples were collected from a randomized group of 142 alcohol-dependent patients. The diagnosis of dependency was made according to the ICD-10 WHO criteria. The values of noninvasive markers were calculated with specific algorithms. The fibrosis stage was evaluated on the basis of FibroTest. The values of APRI, Forns, FIB-4, GAPRI, AP, and Hepascore differ between various stages of liver fibrosis. Patients with fibrosis stage F0 present lower values of APRI, Forns, FIB-4, GAPRI, and Hepascore in comparison to the patients with stages F1 and F0-F1. Patients with fibrosis stages < F2 have lower values of all noninvasive markers than patients with stages ≥F2. Patients with fibrosis stages ≥F2 but <F4 have lower values of APRI, Forns, FIB-4, GAPRI, and Hepascore than patients with stage F4. The values of noninvasive markers tested here differ in various stages of liver fibrosis. To our surprise, the patented marker, Hepascore, achieves a lower diagnostic value in alcoholics than simple markers involving only liver enzymes, platelet count, and cholesterol. The best marker of liver fibrosis in alcoholic patients seems to be the Forns index.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The distribution of noninvasive markers of liver fibrosis in alcoholics.
Figure 2
Figure 2
Spearman's rank correlation between tested noninvasive liver fibrosis markers and FibroTest.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. MacSween R. N. M., Burt A. D. Histologic spectrum of alcoholic liver disease. Seminars in Liver Disease. 1986;6(3):221–232. doi: 10.1055/s-2008-1040605. - DOI - PubMed
    1. O'Shea R. S., Dasarathy S., McCullough A. J., Practice Guideline Committee of the American Association for the Study of Liver Diseases and the Practice Parameters Committee of the American College of Gastroenterology Alcoholic liver disease. Hepatology. 2010;51(1):307–328. doi: 10.1002/hep.23258. - DOI - PubMed
    1. Bruha R., Dvorak K., Petrtyl J. Alcoholic liver disease. World Journal of Hepatology. 2012;4(3):81–90. doi: 10.4254/wjh.v4.i3.81. - DOI - PMC - PubMed
    1. Thanapirom K., Tsochatzis E. A. Non-alcoholic fatty liver disease (NAFLD) and the quest for effective treatments. Hepatobiliary Surgery and Nutrition. 2019;8(1):77–79. doi: 10.21037/hbsn.2018.11.06. - DOI - PMC - PubMed
    1. Menachery John, Duseja Ajay. Treatment of Decompensated Alcoholic Liver Disease. International Journal of Hepatology. 2011;2011:7. doi: 10.4061/2011/219238.219238 - DOI - PMC - PubMed

Publication types